INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$109.14
-6.47 (-5.60%)
▼
5d:
-2.15%
30d:
+18.79%
90d:
-29.5%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Smart Money Distribution
None View Scanner →
Strength: 7.8/10
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called INSM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INSM shows positive signals but monitor for confirmation. Market pricing in 49.7% growth. Moderate conviction.
💡 BUY OPPORTUNITY: INSM shows positive signals but monitor for confirmation. Market pricing in 49.7% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $109.14, which is considered slightly high relative to its 30-day fair value range of $96.13 to $110.96. From a valuation perspective, the stock is trading at a premium (Forward PE: 957.8) compared to its historical average (285.3). At these levels, the market is pricing in 49.7% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $103.08, while resistance sits at $119.54. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $197.05 (+70.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $103.08, while resistance sits at $119.54. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $197.05 (+70.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$96.13 -
$110.96
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 70.4% below Wall St target ($197.05)
- BEARISH: Market expects 49.7% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$96.13 -
$110.96
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$103.08
Resistance Level
$119.54
Current Trend
Strong Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
957.83
Wall Street Target
$197.05
(+70.4%)
Revenue Growth (YoY)
229.6%
Profit Margin
-144.4%
Valuation Premium vs History
+49.7% premium
PE vs Historical
957.8 vs 285.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+49.7%
(market-implied from PE analysis)
1-Year Target
$173.07
(+50%)
2-Year Target
$259.08
(+124%)
3-Year Target
$387.85
(+236%)
3-Yr Target (if PE normalizes)
(PE: 958→285)
PE COMPRESSION
$115.52
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 13, 2026 4:22 PM ET
Data refreshes hourly during market hours. Next update: 5:22 PM
Data refreshes hourly during market hours. Next update: 5:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
William Lewis
SELL
10699 shares
2026-04-16
William Lewis
SELL
10699 shares
2026-04-06
Roger Adsett
SELL
88060 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 64 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 61 BUY |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
